Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies


Welcome to our interactive webinar series with world-leading drug discovery scientists.

Don’t miss your chance to engage with industry thought-leaders on topics that matter in taking drugs from ideas to the clinic.


Next Webinar:

Rethinking Diabetes Drug Discovery

Keld Fosgerau, CEO and Founder at Fosgerau Consult

Weds 27 January, 3pm (UK)

The diabetes pandemic is a reality, currently affecting around 462 million people worldwide and growing rapidly. Many pharmacotherapies have become available for treatment of hyperglycemia, and less innovation is now going in the direction of improving this factor of glycemic control. But where are the next medicines being developed, and what are the un-met medical needs still existing in the area of diabetes and related metabolic disorders? 



On demand webinar access


Latest News

View All

Sygnature Discovery Adopts OpenEye’s Orion™ Platform to…

Sygnature Discovery shortlisted for BioNow Company of…

Sygnature upgrades western blotting capability with Jess…

Dr Paul Overton becomes Chief Commercial Officer…

Get in Touch

For more details on how we can provide innovative support to your project please use this contact form.

CTA Form

The information you supply will be processed in accordance with the General Data Protection Regulation (EU) 2016/679. For further details about how Sygnature Discovery collects, uses and stores personal data, please refer to our Website Privacy Notice available here.